Skip to content

DSM wins patent opposition appeal impacting stereolithography development

Royal DSM, the global Life Sciences and Materials Sciences Company, has won an appeal regarding the opposition of patent EP1232198, titled, UV Curable Compositions at the European Patent Office Board of Appeal in Munich, Germany on January 17, 2014.

DSM parts
DSM parts
Published:

Royal DSM, the global Life Sciences and Materials Sciences Company, has won an appeal regarding the opposition of patent EP1232198, titled, UV Curable Compositions at the European Patent Office Board of Appeal in Munich, Germany on January 17, 2014. This patent, currently assigned to 3D Systems, Inc., was revoked at the European level, thus allowing for increased development of materials in this field.

More in Vat Photopolymerization

See all

More from Jim Woodcock

See all

Our first look at the Rize One

/

From our partners